Tenidap inhibits replication of the human immunodeficiency virus-1 in cultured cells

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 14, Issue 1, 1997, Pages 13-17

  Dezube, Bruce J ^a,c   Ahlers, Christoph M ^a   Lawrence, John P ^a   Teng, Edna I ^a   Silberman, Sandra L ^b   Pardee, Arthur B ^a   Finberg, Robert W ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b PFIZER INC   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

HIV; Interleukin 6; Piroxicam; Tenidap; UK5099

Indexed keywords

2 CYANO 3 (1 PHENYLINDOL 3 YL)ACRYLIC ACID; ARACHIDONIC ACID; INTERLEUKIN 6; PIROXICAM; TENIDAP;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG EFFECT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOREGULATION; LYMPHOCYTE CULTURE; NONHUMAN; PRIORITY JOURNAL; VIRUS EXPRESSION; VIRUS INHIBITION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0031012290     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199701010-00003     Document Type: Article

References (16)

1. Sipe JD, Bartle LM, Loose LD. Modification of proinflammatory cytokine production by the antirheumatic agents tenidap and naproxen. J Immunol 1992;148:480-4.
2. Wylie G. A 24 week study of tenidap vs diclofenac in rheumatoid arthritis. Rev Esp Reumatol 1993;20:142.
3. Kirby DS, Loose LD, Weiner ES, Wilhem FE, Shanahan WR, Ting N. Tenidap vs naproxen treatment of rheumatoid arthritis. Arthritis Rheum 1993;36:112.
4. Kraska AR, Wilhelm FE, Kirby DS, et al. Tenidap vs piroxicam vs piroxicam plus hydroxychloroquine in rheumatoid arthritis. Arthritis Rheum 1993;36:57.
5. Littman BH, Drury CE, Zimmerer RO, Stack CB, Law CG. Rheumatoid arthritis treated with tenidap and piroxicam. Clinical associations with cytokine modulation by tenidap. Arthritis Rheum 1995;38:29-37.
6. Breen EC, Rezai AR, Nakajima K, et al. Infection with HIV is associated with elevated IL-6 levels and production. J Immunol 1990;144:480-4.
7. Poli G, Bressler P, Kinter A, et al. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor α by transcriptional and post-transcriptional mechanisms. J Exp Med 1990;172:151-8.
8. Miles SA, Rezai AR, Salazar-Gonzalez JF, et al. AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proc Natl Acad Sci U S A 1990;87:4068-72.
9. Miles S, Rezai A, Gaynor R, Magpantay L, Kishimoto T, Martinez-Maza O. HIV-tat increases IL-6 production by and proliferation of AIDS-KS derived cells [Abstract]. Seventh Internatl Conference on AIDS. Florence, 1991:Tu.A.5.
10. McNiff PL, Svensson L, Pazoles CJ, Gabel CA. Tenidap modulates cytoplasmic pH and inhibits anion transport in vitro: mechanism and evidence of functional significance. J Immunol 1994;153:2180-93.
11. Marshall WL, Diamond DC, Kowalski MM, Finberg RW. High level of surface CD4 prevents stable human immunodeficiency virus infection of T-cell transfectants. J Virol 1992;66:5492-9.
12. Kishimoto T, Akira S, Taga T. Interleukin-6 and its receptor: a paradigm for cytokines. Science 1992;258:593-7.
13. Koop E, Ghosh S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 1994;265:956-9.
14. Simchowitz L, Davis AO. Intracellular pH recovery from alkalinization: characterization of chloride and bicarbonate transport by the anion exchange system of human neutrophils. J Gen Physiol 1990;96:1037-59.
15. Sperber K, Kalb, TH, Stecher VJ, Banerjee R, Mayer L. Inhibition of human immunodeficiency virus type 1 replication by hydroxychloroquine in T cells and monocytes. AIDS Res Hum Retroviruses 1993;9:91-8.
16. 2, a seminal constituent, facilitates the replication of acquired immune deficiency syndrome virus in vitro. Proc Natl Acad Sci USA 1986;83:3487-90.